Skip to main content
See every side of every news story
Published loading...Updated

Latent Labs emerges from stealth to accelerate drug discovery

  • Latent Labs, co-founded by Simon Kohl, has emerged from stealth with $50 million in funding to advance drug discovery using AI technology.
  • The startup focuses on making biology programmable, enabling researchers to create new therapeutic molecules and proteins without relying on wet labs.
  • The funding round was co-led by Radical Ventures and Sofinnova Partners, with notable angel investors participating.
  • Latent Labs aims to improve drug development timelines and clinical success rates by using AI to design stable proteins.
Insights by Ground AI

8 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

TechCrunch broke the news in United States on Thursday, February 13, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal